Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
复制标题
DOI:
10.1097/rli.0000000000000100
复制
发表时间:
2015-04
影响因子:
6.7
通讯作者:
Yankeelov TE
中科院分区:
文献类型:
--
作者:
Li X;Abramson RG;Arlinghaus LR;Kang H;Chakravarthy AB;Abramson VG;Farley J;Mayer IA;Kelley MC;Meszoely IM;Means-Powell J;Grau AM;Sanders M;Yankeelov TE
To determine if combined measurements from dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) and diffusion weighted MRI (DW-MRI), obtained before and after the first cycle of neoadjuvant chemotherapy (NAC), are superior to single parameter measurements for predicting pathological complete response (pCR) in breast cancer patients. Patients with Stage II/III breast cancer were enrolled in an IRB-approved study in which 3T DCE- and DW-MRI data were acquired before (n = 37) and after one cycle (n = 33) of NAC. Estimates of Ktrans, ve, vp, and kep (= Ktrans/ve) were generated from the DCE-MRI data using the Extended Tofts-Kety (ETK) model. The apparent diffusion coefficient (ADC) was estimated from the DW-MRI data. The derived parameter kep/ADC was compared to single parameter measurements for its ability to predict pCR after the first cycle of NAC. kep/ADC after the first cycle of NAC discriminated patients who went on to achieve a pCR (P < 0.001), and achieved a sensitivity, specificity, positive predictive value, and area under the receiver operator curve (AUC) of 0.92, 0.75, 0.69, and 0.86, respectively. These values were superior to the single parameters kep (AUC = 0.77) and ADC (AUC = 0.81). The AUCs between kep/ADC and kep were significantly different based on the bootstrapped 95% CIs (0.0062, 0.20), while the AUCs between kep/ADC and ADC trended towards significance (−0.12, 0.24). A combined analysis of DCE-MRI and DW-MRI parameters was superior to single-parameter measurements for predicting pCR after the first cycle of NAC.